A clinical trial evaluating a new near-infrared imaging agent to detect cancerous tissue in dogs with Insulinoma during surgical excision.
inactive pancreatic Insulinoma clinical trial cancer active cancer
CHOP vs. LOPP chemotherapy for T-cell Lymphoma
inactive lymphoma lymph node chemotherapy cancer active cancer
This trial will compare outcomes in dogs treated with embolization vs. chemoembolization and will also evaluate the accuracy of contrast enhanced ultrasound verses CT angiogram for post-embolization assessment.
cancer active liver tumors liver cancer hepatocellular carcinoma Embolization dogs with liver tumors dogs with liver cancer CT angiogram Contrast-enhanced ultrasound Chemoembolization active
The purpose of this study is to evaluate different doses of bendamustine in dogs with lymphoma to evaluate its safety and effectiveness.
cancer active lymphoma dogs chemotherapy active
Evaluating the efficacy of a new near-infrared imaging agent when applied topically to tumor during surgery in dogs with mammary gland tumors
female NIRI near-infrared imaging mgt mastectomy massie mammary tumor mammary gland tumor mammary carcinoma mammary adenocarcinoma holt clinical trial Holt cancer active breast cancer active
A clinical trial evaluating a new near-infrared (NIR) imaging agent to detect cancerous tissue in dogs with oral squamous cell carcinoma (SCC) during surgical excision.
Oncology surgical oncology Imaging surgery squamous cell carcinoma skin cancer SCC oral tumor NIRI near-infrared imaging mouth Holt Griffin epithelium epidermis Castejon cancer active cancer active
A clinical trial to determine if near-infrared imaging can improve the surgeon’s ability to see cancer and cancer margins during surgery to remove primary lung tumors in dogs.
cancer active tumor surgery primary lung tumor Oncology metastasis mass margins lung tumor lung mass lung infrared Imaging Dr. David Holt diagnostic imaging comprehensive cancer care canine tumor canine lung tumor canine cancer cancer center cancer advanced imaging active
This study will be the first to assess whether Solensia, in combination with meloxicam, provides superior pain relief compared to meloxicam alone.
Ester Yang medical oncology bone lysis Oncology pain oral cancer mouth squamous cell squamous cell carcinoma SCC Solensia carcinoma cancer active cancer anti-inflammatory active